Phase II study of autologous mRNA electroporated dendritic cells (TriMixDC-MEL) in combination with Ipilimumab in patients with pretreated advanced melanoma
Crossref DOI link: https://doi.org/10.1186/2051-1426-2-S3-P129
Published Online: 2014-11-06
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Thielemans, Kris
Neyns, Bart
Wilgenhof, Sofie
Corthals, Jurgen
Heirman, Carlo
Article History
First Online: 6 November 2014